Literature DB >> 3863127

Specific transcription of preformed nucleoprotein complexes, containing the adenovirus major late promoter, with a chromatographic fraction containing RNA polymerase II.

R J Hellwig, S N Sinha, S K Niyogi.   

Abstract

Incubation in a HeLa whole-cell extract converted a plasmid DNA containing the adenovirus type 2 major late promoter into ordered nucleoprotein complexes similar to those described for simian virus DNA [Sinha, S. N., Hellwig, R. J., Allison, D. P. & Niyogi, S. K. (1982) Nucleic Acids Res. 10, 5533-5552]. Purified nucleoprotein complexes containing the plasmid DNA were able to serve as template for accurate transcription in vitro. Use of such nucleoprotein complexes eliminated the need for addition of nontemplate DNA (poly[d(I-C)]) to transcription reaction mixtures with template concentrations too low to yield a detectable specific-transcription signal from "naked" DNA. Of the four fractions resulting from phosphocellulose column chromatography of the whole cell extract, only the fraction that contained the RNA polymerase II activity was needed to accurately transcribe these nucleoprotein complexes in the presence of human placental ribonuclease inhibitor. In contrast, specific transcription of naked template DNA under these conditions required at least one additional fraction containing specificity factors. These results show that the nucleoprotein complexes contain factor(s) needed for specific initiation of transcription and that these complexes may be useful in the purification and analysis of these factors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3863127      PMCID: PMC390768          DOI: 10.1073/pnas.82.20.6769

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Spliced early mRNAs of simian virus 40.

Authors:  A J Berk; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Mammalian deoxyribonucleic acid-dependent ribonucleic acid polymerases. I. Purification and properties of an -amanitin-sensitive ribonucleic acid polymerase and stimulatory factors from HeLa and KB cells.

Authors:  B Sugden; W Keller
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

3.  T antigen repression of SV40 early transcription from two promoters.

Authors:  U Hansen; D G Tenen; D M Livingston; P A Sharp
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

4.  In vivo sequence requirements of the SV40 early promotor region.

Authors:  C Benoist; P Chambon
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

5.  The SV40 early region TATA box is required for accurate in vitro initiation of transcription.

Authors:  D J Mathis; P Chambon
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

6.  DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.

Authors:  J L Manley; A Fire; A Cano; P A Sharp; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

7.  In vitro transcription of normal, mutant, and truncated mouse alpha-globin genes.

Authors:  C A Talkington; Y Nishioka; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

8.  Multiple factors required for accurate initiation of transcription by purified RNA polymerase II.

Authors:  T Matsui; J Segall; P A Weil; R G Roeder
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

9.  Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNA.

Authors:  P A Weil; D S Luse; J Segall; R G Roeder
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

10.  Transcription factors from oviduct and HeLa cells are similar.

Authors:  S Y Tsai; M J Tsai; L E Kops; P P Minghetti; B W O'Malley
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

View more
  1 in total

1.  C-myc gene binding factors in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE).

Authors:  Y Deguchi; S Negoro; T Hosokawa; S Kishimoto
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.